Minimally disruptive medicine: the evidence and conceptual progress supporting a new era of healthcare by Abu Dabrh, A.M. et al.
114
J R Coll Physicians Edinb 2015 45: 114–7
http://dx.doi.org/10.4997/JRCPE.2015.205
© 2015 Royal College of Physicians of Edinburgh
IntroductIon
In this era of modern medicine, there has been a well-
documented rise in the prevalence of chronic conditions 
and multimorbidity.1,2 This rise has been accompanied by 
a proliferation of treatment options and advances in 
clinical outcomes, but also by an increase in demands 
and potential challenges for patients. A continuous focus 
on disease-centred clinical care and guideline 
development, as well as a population-level oriented 
approach to disease management, has resulted in a lack 
of insight into whether the needs of patients with 
multimorbidity and chronic disease are met effectively 
by health services.3,4 Guidelines focus on clinical 
outcomes without taking consideration of the capacity, 
abilities and limitations of patients to manage their daily 
care. They also discount the workload, demands and 
responsibilities that accompany these treatment 
regimens. The continuous and complex interaction 
between workload and capacity is fluid and sensitive to 
changes in the individual, their health, social networks 
and environment. By neglecting this balance, disease-
centred approaches may inadvertently increase the risk 
of adverse events and result in poorly co-ordinated, 
fragmented care.3,4 Healthcare needs reshaping, and a 
new era of medicine is evolving: minimally disruptive 
medicine (MDM).5 Here we describe the emerging 
evidence base behind this exciting new concept, by 
discussing: i) the workload of healthcare for patients; ii) 
why individual capacity can affect outcomes; iii) the 
challenges posed by multimorbidity: and iv) the role of 
MDM in addressing these issues.
the work of healthcare for patIents
Patients with long term conditions often face considerable 
encumbrance from their illness, for example physical 
symptoms, psychological difficulties and financial hardship 
due to lost employment. Alongside this burden of illness 
there is another hardship that is often overlooked, the 
burden of treatment (BOT). This multi-dimensional 
phenomenon describes the added and ongoing workload 
(i.e. requirements and demands) for patients in order for 
them to adhere to recommendations made by their 
clinicians to manage their morbidity and wellbeing.6 It 
also reflects the barriers patients face as they navigate 
through this journey of healthcare. Treatment workload 
encompasses the tasks carried out by patients to 
manage their illness (e.g. taking medications, reading 
information leaflets, arranging transportation to 
appointments, making lifestyle changes).6,7 The BOT is 
likely to be affected by the nature of the illness and 
treatments available (e.g. number and frequency of visits, 
managing transportation), presence of comorbidities 
(each comorbidity adds visits to the clinic, claim forms, 
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medications and paper work) and, importantly, the 
organisation of health services and the practices of 
health practitioners.5,8,9 The BOT is likely to vary 
between places due to differences in healthcare settings 
or systems. For example, financial obstacles are more 
likely to be found in healthcare systems that require 
patients to negotiate with insurers (such as in the US) 
than in universal healthcare systems where care is free 
at the point of contact (such as in the UK).10
There has been a recent shift towards self-management 
and community rehabilitation with the aim of cutting 
costs and improving patient outcomes;11,12 however 
these changes are likely to fundamentally shift the work 
of treatment from health professionals towards patients 
and their caregivers. In response to these changes, 
patients and their caregivers may make considerable 
efforts to minimise burdens imposed on them by health 
systems, further adding to their everyday workload 
(utilising social networks, using problem based strategies 
and relying on emotion based coping techniques).13 
Identifying this burden may help clinicians better 
understand the demands that follow from their 
recommendations and help patients to better manage 
and adhere to proposed regimens. 
There is growing evidence of BOT for those with 
chronic conditions. Patient-reported measures have 
been used to quantify aspects of BOT in various 
conditions such as diabetes, chronic heart failure, cancer, 
chronic obstructive pulmonary disease and cystic 
fibrosis. Types of measured BOT include time and effort 
spent following medication regimes,14 side effects of 
treatment,15 and out-of-pocket expenditure.16 A recent 
systematic review examined patient reported measures 
of BOT in chronic heart failure, diabetes and chronic 
kidney disease and found that the majority of studies 
lacked direct patient input and did not show evidence of 
reliability of the measures used.17 However, there has 
been recent interest in the development of more 
broadly focused patient-reported measures.6,18,19 These 
measurements look promising and are currently being 
validated in different populations and settings. A plethora 
of qualitative work has also appeared in the literature, 
exploring the patient experience of treatment burden in 
stroke, chronic heart failure, end of life care, and 
multimorbidity.7,20-22 This qualitative work complements 
the aforementioned quantitative work, both by informing 
the development of measures of BOT and also by 
supplying deeper insight into the patient perspective.
patIent capacIty
Capacity refers to the abilities and resources the patient 
can mobilise to address, manage, and cope with the 
demands of healthcare and life.23 If capacity is limited or 
capped then this impacts on the ‘ability or readiness of 
the individual to do work’.23 Capacity relates to a range 
of areas of patients’ lives, such as their available time 
and their personal, physical, emotional, social, 
environmental, and financial capacity. Accompanying the 
concept of treatment burden is the acknowledgement 
that there is considerable variation between patients 
with regards their capacity to cope with a given 
treatment workload, depending on social support 
systems and other personal commitments. It is well 
recognised that an individual’s ability to follow 
treatments and engage with health professionals can be 
affected by both environmental factors such as social 
support and financial constraints24 and internal factors 
such as health literacy and resilience.25 Similarly to BOT, 
the conceptualisation of patient capacity has preceded 
the development of methods of measurement. However, 
certain available patient reported measures do consider 
aspects of capacity, including self-efficacy and the 
intrusion of illness on everyday life26 or the effects of 
disabilities such as visual or hearing impairments.27 
Capacity influences health and vice versa. In a recent 
systematic review, supporting patient capacity in 
interventions was associated with greater effectiveness 
in reducing 30-day hospital readmissions.28 
the (Im)Balance Between capacIty and 
workload
Workload and capacity are interrelated and may be in 
balance or imbalance with one another as the Cumulative 
Complexity Model describes (Figure 1).23 This model 
makes apparent the self-reinforcing cycle in which adding 
treatment to patients with high workload and low 
capacity may diminish self-care, adherence to therapies, 
quality of life, and health outcomes. The concepts of 
workload and patient capacity have been further 
conceptualised by development of Burden of Treatment 
Theory.8 This theorises healthcare utilisation as an 
undertaking that is characterised by individuals and their 
support networks navigating through health services and 
their associated clinicians. 
Along with their support networks, individuals possess 
the ability to perform healthcare tasks, secure 
co-operation of others and add to their social capital, 
thus reinforcing the resilience of their network. This 
emphasises the relational aspects of healthcare provision 
and the importance of resources for both clinicians and 
patient, with maximum benefits only being gained from 
services if patients are given the wherewithal to use them.
multImorBIdIty
One important factor that affects the workload-capacity 
balance is the presence and extent of multimorbidity.18 
Those with multiple conditions are more likely to have 
diminished capacity due to associated factors such as 
poor physical and mental health, including the effects of 
burden of symptoms, lack of employment and higher 
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levels of deprivation. Treatment burden is also likely to 
be increased due to, for example, higher numbers of 
treatments and polypharmacy, increased risk of adverse 
events and poorly co-ordinated care. Consideration of 
comorbidities is therefore vital when assessing and 
managing workload and implementing support for those 
with long term conditions.2 
the case for mInImally dIsruptIve 
medIcIne
The complex interaction of disease, treatment, and 
experience in multimorbid patients suggests that the 
appropriate unit of treatment is not each condition 
considered separately or even combined. The appropriate 
focus of treatment is the situation and the individual 
tackled as a whole. Concepts such as workload, burden 
and capacity direct attention to the situation in which 
the patient and their carers exist while living with illness. 
Importantly, these concepts also direct our attention to 
issues which healthcare and clinicians are often blind—
the extent to which a healthcare-created burden 
inadvertently drags people down. 
Minimally disruptive medicine is a patient-centred 
approach that asks the question; what is the situation 
that demands medicine, and, what is the medicine that 
the situation demands?29 In attending to the patient’s 
unique situation and morbidity, MDM recognises that 
guidelines and standard processes only partially address 
the key issues for any given individual. Such guidelines 
are useful hypotheses for approaching practice, but they 
should be interrogated in terms of how they serve the 
person at hand. In considering the situation through the 
lens that guidelines or routine treatments and tests 
provide, questions about the feasibility, viability and 
desirability of treatment must be asked. In approaching 
the feasibility of treatment, MDM considers if and how it 
is possible to instigate a considered intervention, for 
instance; does the patient have the necessary capacity 
and relational support to undertake the work of 
treatment, and are the limited resources of real 
healthcare settings appropriately acknowledged in 
passing the work of treatment on to patients? Viability 
goes beyond asking if it is possible to instigate treatment 
in the short term but to consider the longitudinal 
aspects of an intervention – what would life look like 
with this treatment in place, is it sustainable and at what 
cost, how might it change over time? Desirability asks 
necessary questions of the value of a considered 
treatment plan – who recognises the intervention as 
desirable, what is the hoped for value of the intervention 
in the patient’s life?
When standard practices and guidelines do not 
adequately answer these questions, invention and 
adaptation are necessary. These may include approaches 
to maximise the benefit of limited healthcare or patient 
resources, reshaping the working relationship of patient 
and clinicians, adjusting goals, shared decision making, 
streamlining medication regimens, and strengthening 
relationships with the community. An exemplar MDM 
toolkit is available, with tools such as ‘goal elicitation’, 
‘capacity assessments’, ‘workload assessments’ ,‘resource 
registries’ and ’medication therapy management tool’.30 
These tools and others in development provide patients 
and clinicians with practical means to do justice to the 
question of patient-centred care.
To enable the practice of MDM, particularly in pay-for 
-performance-systems, guidelines should be amended to 
take account of multimorbidity and incentives should be 
created for well-coordinated care that minimises 
treatment burden for patients.9 Over the past decade, 
there has been a call for the practice of more thoughtful 
care for patients and the call for MDM complements this 
notion.6 It encourages clinicians to provide holistic care 
that realistically considers the burdens imposed on 
patients from healthcare systems and other aspects of 
their life. Some of these changes will require considerable 
investment from governing bodies, but MDM is designed 
to be a cost-effective way of caring for patients, as 
wasted resources are minimised and healthcare 
utilisation is rationalised. The aforementioned evidence 
suggests that by practising MDM, we can not only 
improve outcomes but also reduce preventable 
healthcare utilisation such as readmission to hospital.28 
Capacity
• Financial resources
• Social capital e.g.
 family support
• Employment
• Time available
• Personality
• Education & literacy
• Disablities
• Symptoms (pain, low 
 mood, breathlessness)
• Resilience
• Cognitive 
 impairment
• Information gathering 
 & comprehension
• Planning e.g. goal
 setting
• Interacting with 
 health & social care
 professionals
• Attending 
 appointments
• Logistical work e.g.
 transport, 
 prescriptions
• Operationalising
 treatments e.g. 
 medications, lifestyle
• Side effects
• Self-monitoring
Workload
Figure 1 Determinants of capacity and workload on 
either side of a balanced scale. If a patient’s capacity is large 
enough to cope with their workload then there is 
equilibrium. When workload outweighs capacity the balance 
is lost and negative outcomes occur.
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Here we have outlined the evidence base behind MDM, 
a new way of delivering healthcare from the clinical 
consultation to the creation of guidelines and healthcare 
policy. Minimally disruptive medicine is exciting and 
innovative in that it is designed to provide comprehensive, 
evidence-based, supportive care that fits into the 
patient’s life. It opens an honest dialogue with patients 
about how they are coping with their illness and 
treatment. Rather than following disease-centred 
guidelines and targets, goals are shifted towards 
improving patient wellbeing and valuing an individuals’ 
capacity to pursue their life’s hopes and dreams. 
Minimally disruptive medicine is not just a novel way of 
thinking; it is a way forward in caring, and one that will 
transform healthcare as we know it.
